Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been recommended as a long term growth pick according to Beta Research. With their stock price currently trading around $461.13, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 38.80% earnings per share growth over the past 5 years and 61.30% revenue growth over that same time frame.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s stock was 25.62%. Over the last week of the month, it was 1.21%, -7.22% over the last quarter, and 25.62% for the past six months.
Over the past 50 days, Regeneron Pharmaceuticals, Inc.’s stock is -8.78% off of the high and 8.13% removed from the low. Their 52-Week High and Low are as follows: -15.16% (High), 41.73%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $496.22 on the equity. Analysts have a consensus recommendation of 2.30 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.